Source: Annual Congress 2004 - Role of infection in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. W. Jones, S. Spencer, I. Duprat-Lomon, P. P. Sagnier, R. Wilson (London, Uxbridge, United Kingdom; Puteaux, France). Short-term recovery in SGRQ following a COPD exacerbation in the MOSAIC study correlates with the preceding deterioration, but is larger. Eur Respir J 2004; 24: Suppl. 48, 4201

Member's Comments

No comment yet.

Related content which might interest you: Value of measuring SGRQ at stable phase of COPD to predict the timing and deterioration associated with next exacerbation: the MOSAIC study Source: Eur Respir J 2004; 24: Suppl. 48, 240s Year: 2004 Short physical performance battery as a predictor of adverse outcomes following hospitalisation for an acute exacerbation of COPD Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases Year: 2016 Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Changes in physical activity and sleep duration following hospitalisation with acute exacerbation of COPD Source: Annual Congress 2012 - The latest insights in chronic care Year: 2012 Early occurrence of any COPD exacerbation predicts further higher risk of moderate/severe exacerbations regardless of recording tool: the FLAME study Source: International Congress 2017 – Management of COPD Year: 2017 Ensifentrine added on to tiotropium significantly improves lung function, symptoms and QoL in symptomatic COPD patients regardless of baseline reversibility Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 Long-term outcome following first clinically important deterioration in COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 The EQ-5D is responsive to recovery from a moderate COPD exacerbation Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009 Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007 Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 6MWT improvement after pulmonary rehabilitation (PR) is inversely associated with degree of airflow obstruction in COPD patients. A retrospective study Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013 Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Short-term HRQL deterioration during early-phase COPD exacerbation: a prospective Canadian cohort study Source: Eur Respir J 2005; 26: Suppl. 49, 296s Year: 2005 Daytime physical activity and sleep quality as related to patient-reported and physiological outcomes following severe COPD exacerbation Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021 Does the duration of symptoms pre admission influence the clinical course of the exacerbation in COPD? Source: Eur Respir J 2004; 24: Suppl. 48, 15s Year: 2004 Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Cognitive decline following an acute exacerbation of COPD (AECOPD) Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Both moderate and severe exacerbations accelerate physical activity decline in COPD patients Source: Eur Respir J, 51 (1) 1702110; 10.1183/13993003.02110-2017 Year: 2018 COPD exacerbations significantly impact quality of life as measured by SGRQ-C total score: results from the FLAME study Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017